Free Research Report on Opko Health, Inc., ACADIA Pharmaceuticals, Inc., Simcere Pharmaceutical Group, SciClone Pharmaceuticals,

   Free Research Report on Opko Health, Inc., ACADIA Pharmaceuticals, Inc.,
  Simcere Pharmaceutical Group, SciClone Pharmaceuticals, Inc. and Sequenom,
                                     Inc.

PR Newswire

NEW YORK, January 30, 2013

NEW YORK, January 30, 2013 /PRNewswire/ --

Today, Traders Insight announced new research reports highlighting Opko
Health, Inc. (NYSE MKT: OPK), ACADIA Pharmaceuticals, Inc. (Nasdaq: ACAD),
Simcere Pharmaceutical Group (NYSE: SCR), SciClone Pharmaceuticals, Inc.
(Nasdaq: SCLN) and Sequenom, Inc. (Nasdaq: SQNM). Today's readers may access
these reports free of charge - including full price targets, industry analysis
and analyst ratings - via the links below.

Opko Health, Inc. Research Report
OPKO Health, Inc. (OPKO) is a multi-national pharmaceutical and diagnostics
company that develops solutions to diagnose, treat and prevent various
conditions, including molecular diagnostics tests, point-of-care tests, and
pharmaceuticals and vaccines. Its lead program is a molecular diagnostics
platform for the development and commercialization of blood-based tests for
conditions. The Full Research Report on Opko Health, Inc. - including full
detailed breakdown, analyst ratings and price targets - is available to
download free of charge at:
[http://www.TradersInsight.net/r/2013-01-29/9b21_OPK]

ACADIA Pharmaceuticals, Inc. Research Report
ACADIA Pharmaceuticals Inc. is a biopharmaceutical company focused on small
molecule drugs that address unmet medical needs in neurological and related
central nervous system disorders. The Company has four product candidates in
clinical development led by pimavanserin, which is in Phase III development as
a first-in-class treatment for Parkinson's disease psychosis. It holds
worldwide commercialization rights to pimavanserin. The Full Research Report
on ACADIA Pharmaceuticals, Inc. - including full detailed breakdown, analyst
ratings and price targets - is available to download free of charge at:
[http://www.TradersInsight.net/r/2013-01-29/7464_ACAD]

Simcere Pharmaceutical Group Research Report
Simcere Pharmaceutical Group is a holding company. The Company principally
engaged in the research, development, manufacture and distribution of
pharmaceutical and vaccine products in the People's Republic of China. As of
December 31, 2011, it manufactured and sold 47 pharmaceutical products and is
the distributor of two additional pharmaceutical products that are marketed
under its brand names. The Full Research Report on Simcere Pharmaceutical
Group - including full detailed breakdown, analyst ratings and price targets -
is available to download free of charge at:
[http://www.TradersInsight.net/r/2013-01-29/9d9c_SCR]

SciClone Pharmaceuticals, Inc. Research Report
SciClone Pharmaceuticals, Inc. (SciClone) is a specialty pharmaceutical
company. The Company has a product portfolio of therapies for oncology,
infectious diseases, cardiovascular, urological, respiratory and central
nervous system disorders. The Company's main product is ZADAXIN (thymalfasin),
which is approved in over 30 countries, which is used for the treatment of
hepatitis B virus (HBV), hepatitis C (HCV), as a vaccine adjuvant, and certain
cancers. The Full Research Report on SciClone Pharmaceuticals, Inc. -
including full detailed breakdown, analyst ratings and price targets - is
available to download free of charge at:
[http://www.TradersInsight.net/r/2013-01-29/92e8_SCLN]

Sequenom, Inc. Research Report
Manufactures DNA detection and sequencing equipment. The Company's two
business units combine to utilize their MassARRAY system, SNP assay portfolio,
disease gene discovery programs and DNA sample repository. Sequenom provides
genetic analysis products that translate genomic science into solutions for
biomedical research, molecular medicine and agricultural applications. More
from Reuters » The Full Research Report on Sequenom, Inc. - including full
detailed breakdown, analyst ratings and price targets - is available to
download free of charge at:
[http://www.TradersInsight.net/r/2013-01-29/2401_SQNM]

About Traders Insight
Our model of enabling open collaboration between members is breaking new
ground into the investment community. By tapping into the resources of the
community, we are crowd-sourcing our reach. As a result -- we have been able
to identify some of the greatest moving companies on the market today. The
evidence is in the results, join today and experience what you've been
missing.

Press Contact:

Cora S. Patton
press@TradersInsight.net

+1-203-297-6092 (North America)

SOURCE Traders Insight
 
Press spacebar to pause and continue. Press esc to stop.